Showing 2081 - 2090 of 3131 for "Pharmaceuticals and life sciences" with applied filters
11 July 2023 by LexOrbis - India: Manisha Singh (Partner) & Vaneet Kaur (Senior Associate)
RNA molecules have been utilized as therapeutic and research tools for more than two decades, with the usage ranging from in vitro transcribed (IVT) mRNA, small interference RNA (siRNA), RNA aptamers, riboswitches, and antisense RNA to the recently developed mRNA vaccines.
05 July 2023 by Lee & Ko - South Korea
The Special Act on the Promotion of Dispersed Energy (the Dispersed Energy Act) was recently enacted as of June 13, 2023 and, on the same date, the amendment to the Electric Utility Act (also known as the Electricity Business Act) (the Amendment) was also promulgated, both of which will come into force as of June 14, 2024.
03 July 2023 by Anand and Anand - India
For several years, patent owners navigated the SEP landscape in India, unsure of their destination (injunction, damages, FRAND verdicts), and wondering whether their opponents (implementers of SEPs) could be made to deposit security, to protect the SEP owners’ interests.
03 July 2023 by Jipyong - South Korea
Foreign contractors and subcontractors doing business with Korean companies are often puzzled by how Korean courts deal with liquidated damages and penalty clauses in contracts.
27 June 2023 by Anand and Anand - India
The firm has won Luxury law Firm Award twice earlier; only Indian firm to be so recognised
21 June 2023 by Jipyong - South Korea
The Serious Accidents Punishment Act (“SAPA”) is a relatively new legislation that came into force on January 27, 2022.
08 June 2023 by Rahul Chaudhry & Partners - India: Sakshi Mathur, Associate
Personality rights, commonly known as ‘right of publicity,’ guarantees an individual right in one’s personal attributes such as appearance, signature, voice, silhouette, face, features, gestures, expressions, mannerisms etc, paving way for an individual to use and commercialise one’s identity.
31 May 2023 by Lee & Ko - South Korea
On 22 May 2023, the Ministry of Employment and Labor (MOEL) announced a significant update to its “Guidelines for Workplace Risk Assessment“ (Guidelines), effective immediately.
30 May 2023 by Lee & Ko - South Korea
Lee & Ko’s Antitrust & Competition Group successfully represented three major Korean shipbuilding companies in the court action involving Gaztransport & Technigaz SA (GTT), the exclusive holder of key patents in technology for manufacturing/constructing membrane storage tanks used on liquefied natural gas carriers (LNG Carrier).
26 May 2023 by Lee & Ko - South Korea
ChatGPT is a conversational artificial intelligence (AI) service based on Generative Pre-trained Transformer (GPT), a language model grounded in artificial neural networks, developed by OpenAI.
Register for FREE and enjoy the following benefits:
IFLR1000's Ranking Analysis allows you to:
Subscribe today, simply call +44 (0)20 7779 8154 or email rvalmarana@legalmediagroup.com
IFLR1000's Ranking Analysis allows you to:
Subscribe today, simply call +44 (0)20 7779 8154 or email rvalmarana@legalmediagroup.com
